The outlook is rosy for the most flexible and adaptable, pharma business leaders agree
23 November 2009
Eleanor Malone
Please Login to read the full article.
23 November 2009
Eleanor Malone
eleanor.malone@informa.com
Despite the dreaded patent cliff, spiralling costs of R&D and increasingly demanding regulatory hurdles, big pharma still has opportunities for growth and there remain huge areas of unmet medical need. But adaptability will be key, according to business leaders speaking at the FT Global Pharmaceutical...
Please Login to read the full article.
RELATED CONTENT
COMMENT
Other Informa Comment
FEATURES
Other Informa Features
EVENTS
26 February 2012
Vancouver Convention Centre | Vancouver, BC, Canada
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
